Cases & Deals

  • Home
  • Practices
  • Publicly traded U.S. life sciences company investigates unauthorized cyber intrusion

Share

Publicly traded U.S. life sciences company investigates unauthorized cyber intrusion

June 2022

Client(s) U.S. life sciences company

Jones Day assisted a publicly traded U.S. life sciences company in its response to an unauthorized cyber intrusion and extortion demand. Jones Day directed an extensive privileged investigation into the incident, engaged with law enforcement, and counseled the client on regulatory notification obligations. Jones Day also assisted the company in its communications with customers regarding the incident and advised on legal risk mitigation strategies.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.